Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C

Clin Immunol. 2015 Dec;161(2):197-208. doi: 10.1016/j.clim.2015.09.003. Epub 2015 Sep 8.

Abstract

Human papillomavirus (HPV)-mediated suppression of Langerhans cell (LC) function can lead to persistent infection and development of cervical intraepithelial neoplasia (CIN). Women with HPV-induced high-grade CIN2/3 have not mounted an effective immune response against HPV, yet it is unknown if LC-mediated T cell activation from such women is functionally impaired against HPV. We investigated the functional activation of in vitro generated LC and their ability to induce HPV16-specific T cells from CIN2/3 patients after exposure to HPV16 followed by treatment with stabilized Poly-I:C (s-Poly-I:C). LC from patients exposed to HPV16 demonstrated a lack of costimulatory molecule expression, inflammatory cytokine secretion, and chemokine-directed migration. Conversely, s-Poly-I:C caused significant phenotypic and functional activation of HPV16-exposed LC, which resulted in de novo generation of HPV16-specific CD8(+) T cells. Our results highlight that LC of women with a history of persistent HPV infection can present HPV antigens and are capable of inducing an adaptive T cell immune response when given the proper stimulus, suggesting that s-Poly-I:C compounds may be attractive immunomodulators for LC-mediated clearance of persistent HPV infection.

Keywords: HPV16; Human papillomavirus; Immune evasion; Langerhans cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / virology
  • DNA, Viral / immunology
  • Female
  • Human papillomavirus 16 / immunology*
  • Humans
  • Langerhans Cells / immunology*
  • Langerhans Cells / virology
  • Lymphocyte Activation / immunology*
  • Middle Aged
  • Papillomavirus Infections / immunology*
  • Papillomavirus Infections / virology
  • Poly I-C / immunology*
  • Uterine Cervical Dysplasia / immunology*
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / immunology
  • Uterine Cervical Neoplasms / virology

Substances

  • DNA, Viral
  • Poly I-C